Rockville-based AdLyfe is the latest company to receive a piece of the $84 million InvestMaryland fund.
Founded in 2003, the biotech company’s “Pronucleon technology platform is intended to help diagnose Alzheimer’s, Parkinson’s and other diseases early,” reports the Baltimore Business Journal.
Read the full story at the Baltimore Business Journal.
As Technically Baltimore has reported, the state’s $84 million venture capital fund will be paid out in $28 million installments over three years, with venture capital firms managing and investing two-thirds of the InvestMaryland fund money.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.
When global tech association CompTIA spun off its nonprofit arm, the TechGirlz curriculum went dark
The fall of giants: How technical leadership gaps broke three once-mighty tech companies
Hey Baltimore: How well do you know local tech news?
